BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21912092)

  • 1. Identification of CD133+ cells in pituitary adenomas.
    Yunoue S; Arita K; Kawano H; Uchida H; Tokimura H; Hirano H
    Neuroendocrinology; 2011; 94(4):302-12. PubMed ID: 21912092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of brain tumor stem progenitor-like cells with low proliferative capacity in human benign pituitary adenoma.
    Chen L; Ye H; Wang X; Tang X; Mao Y; Zhao Y; Wu Z; Mao XO; Xie L; Jin K; Yao Y
    Cancer Lett; 2014 Jul; 349(1):61-6. PubMed ID: 24732807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of neural stem cell surface marker CD133 in balloon cells of human focal cortical dysplasia.
    Ying Z; Gonzalez-Martinez J; Tilelli C; Bingaman W; Najm I
    Epilepsia; 2005 Nov; 46(11):1716-23. PubMed ID: 16302851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlative study of distribution of brain tumor stem cell with micro-vascular system].
    Li MW; Niu CS
    Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(5):305-9. PubMed ID: 20368050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating endothelial progenitor cells and depression: a possible novel link between heart and soul.
    Dome P; Teleki Z; Rihmer Z; Peter L; Dobos J; Kenessey I; Tovari J; Timar J; Paku S; Kovacs G; Dome B
    Mol Psychiatry; 2009 May; 14(5):523-31. PubMed ID: 18180758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of putative stem marker nestin and CD133 in advanced serous ovarian cancer.
    Qin Q; Sun Y; Fei M; Zhang J; Jia Y; Gu M; Xia R; Chen S; Deng A
    Neoplasma; 2012; 59(3):310-5. PubMed ID: 22296500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of nestin in the non-tumorous hypophysis and in pituitary neoplasms.
    Rotondo F; Kovacs K; Horvath E; Bell CD; Lloyd RV; Scheithauer BW
    Acta Neuropathol; 2006 Mar; 111(3):272-7. PubMed ID: 16538520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of CD133-, CD34- and KDR-positive cells in the bovine ovary: a new site of vascular wall resident endothelial progenitor cells.
    Schoen K; Hirschberg RM; Plendl J; Kaessmeyer S
    Clin Hemorheol Microcirc; 2012; 52(2-4):67-84. PubMed ID: 22954638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors.
    Timmermans F; Van Hauwermeiren F; De Smedt M; Raedt R; Plasschaert F; De Buyzere ML; Gillebert TC; Plum J; Vandekerckhove B
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1572-9. PubMed ID: 17495235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A distinct subpopulation within CD133 positive brain tumor cells shares characteristics with endothelial progenitor cells.
    Choi SA; Wang KC; Phi JH; Lee JY; Park CK; Park SH; Kim SK
    Cancer Lett; 2012 Nov; 324(2):221-30. PubMed ID: 22652175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isolation and characterization of brain tumor stem cells in human medulloblastoma].
    Li MC; Deng YW; Wu J; Chen FH; Liu JF; Fang JS
    Ai Zheng; 2006 Feb; 25(2):241-6. PubMed ID: 16480595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD133 expression and identification of CD133/nestin positive cells in rhabdomyosarcomas and rhabdomyosarcoma cell lines.
    Sana J; Zambo I; Skoda J; Neradil J; Chlapek P; Hermanova M; Mudry P; Vasikova A; Zitterbart K; Hampl A; Sterba J; Veselska R
    Anal Cell Pathol (Amst); 2011; 34(6):303-18. PubMed ID: 22156015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathological characteristics of glioma stem cell niches.
    He H; Li MW; Niu CS
    J Clin Neurosci; 2012 Jan; 19(1):121-7. PubMed ID: 22178090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of multidrug resistance genes in normal and cancer stem cells.
    Shervington A; Lu C
    Cancer Invest; 2008 Jun; 26(5):535-42. PubMed ID: 18568776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the stem cell markers nestin and CD133 on circulating melanoma cells.
    Fusi A; Reichelt U; Busse A; Ochsenreither S; Rietz A; Maisel M; Keilholz U
    J Invest Dermatol; 2011 Feb; 131(2):487-94. PubMed ID: 20882037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WNT-conditioned media differentially affect the proliferation and differentiation of cord blood-derived CD133+ cells in vitro.
    Nikolova T; Wu M; Brumbarov K; Alt R; Opitz H; Boheler KR; Cross M; Wobus AM
    Differentiation; 2007 Feb; 75(2):100-11. PubMed ID: 17316380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines.
    Veselska R; Hermanova M; Loja T; Chlapek P; Zambo I; Vesely K; Zitterbart K; Sterba J
    BMC Cancer; 2008 Oct; 8():300. PubMed ID: 18925963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor binding proteins-2 and -4 enhance the migration of human CD34-/CD133+ hematopoietic stem and progenitor cells.
    Bartling B; Koch A; Simm A; Scheubel R; Silber RE; Santos AN
    Int J Mol Med; 2010 Jan; 25(1):89-96. PubMed ID: 19956906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of growth-related factors in human pituitary adenomas. Lowered insulin-like growth factor-I and its receptor mRNA in growth hormone-producing adenomas.
    Otsuka F; Tamiya T; Yamauchi T; Ogura T; Ohmoto T; Makino H
    Regul Pept; 1999 Aug; 83(1):31-8. PubMed ID: 10498342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas.
    Niveiro M; Aranda FI; Peiró G; Alenda C; Picó A
    Hum Pathol; 2005 Oct; 36(10):1090-5. PubMed ID: 16226108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.